Literature DB >> 22297152

Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy.

Young-Eun Park1, Hyang-Sook Kim, Chang-Hoon Lee, Tai-Seung Nam, Young-Chul Choi, Dae-Seong Kim.   

Abstract

Dysferlinopathy refers to autosomal recessive muscular dystrophies caused by mutations in dysferlin gene (DYSF). It includes two major distinct disorders, Miyoshi myopathy and limb-girdle muscular dystrophy type 2B. Twenty-three Korean patients were recruited. Full sequence analysis of DYSF detected 10 novel and 9 known mutations. The p.Gln832X showed the highest allele frequency (10/46) as a unique recurrent mutation among Korean population, and two common mutations (p.Gln832X and c.663+1G>C) accounted for 34.8% of the identified mutations. Korean DYSF mutations appeared to cluster in the N-terminal region. Notably, none of homozygous mutations was found in this study. Clinical features were similar to previous reports showing onset in early adulthood, high serum CK and inflammatory reactions on muscle pathology. In Miyoshi myopathy, gastrocnemius muscle was first affected on muscle CT scans, and anterior lower legs and thigh muscles were then affected with disease progression. Despite the genetic variety of DYSF mutations, clinical features were rather invariable among the patients.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297152     DOI: 10.1016/j.nmd.2011.12.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

Review 1.  Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.

Authors:  Cecilia Contreras-Cubas; Francisco Barajas-Olmos; Maria Inés Frayre-Martínez; Georgina Siordia-Reyes; Claudia C Guízar-Sánchez; Humberto García-Ortiz; Lorena Orozco; Vicente Baca
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

2.  Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.

Authors:  Samya Chakravorty; Babi Ramesh Reddy Nallamilli; Satish Vasant Khadilkar; Madhu Bala Singla; Ashish Bhutada; Rashna Dastur; Pradnya Satish Gaitonde; Laura E Rufibach; Logan Gloster; Madhuri Hegde
Journal:  Front Neurol       Date:  2020-11-05       Impact factor: 4.086

3.  Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy.

Authors:  Su-Qin Jin; Meng Yu; Wei Zhang; He Lyu; Yun Yuan; Zhao-Xia Wang
Journal:  Chin Med J (Engl)       Date:  2016-10-05       Impact factor: 2.628

4.  Polymyositis without Beneficial Response to Steroid Therapy: Should Miyoshi Myopathy be a Differential Diagnosis?

Authors:  Renata Siciliani Scalco; Paulo José Lorenzoni; David S Lynch; William Alves Martins; Heinz Jungbluth; Ros Quinlivan; Jefferson Becker; Henry Houlden
Journal:  Am J Case Rep       Date:  2017-01-05

5.  Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing.

Authors:  Meng Yu; Yiming Zheng; Suqin Jin; Qiang Gang; Qingqing Wang; Peng Yu; He Lv; Wei Zhang; Yun Yuan; Zhaoxia Wang
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

6.  Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation.

Authors:  Kyowon Seo; Eun Kyoung Kim; Jaeil Choi; Dae-Seong Kim; Jin-Hong Shin
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-01       Impact factor: 6.698

Review 7.  Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).

Authors:  Omar A Mahmood; Xin Mei Jiang
Journal:  Mol Med Rep       Date:  2014-03-13       Impact factor: 2.952

8.  miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy.

Authors:  Gang Li; Qing-Shan Li; Wen-Bin Li; Jian Wei; Wen-Kai Chang; Zhi Chen; Hu-Yun Qiao; Ying-Wei Jia; Jiang-Hua Tian; Bing-Sheng Liang
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

9.  Genetically confirmed limb-girdle muscular dystrophy type 2B with DYSF mutation using gene panel sequencing: A case report.

Authors:  Sook Joung Lee; Eunseok Choi; Soyoung Shin; Joonhong Park
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.